Bio-Techne Receives Shareholders' Approval For Proposed Acquisition By Merck KGaA

Bio-Techne Corporation (NASDAQ: TECH) has received shareholder approval for its proposed acquisition by Merck KGaA, as announced during a Special Meeting of Shareholders. The approval pertains to the definitive agreement under which Merck KGaA intends to acquire Bio-Techne.